Bandage Contact Lenses Versus Eye Patching of Müller's Muscle-conjunctival Resection
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04554329 |
|
Recruitment Status :
Completed
First Posted : September 18, 2020
Last Update Posted : September 18, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Eyelid Diseases | Procedure: bandage contact lens | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 40 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Efficacy of Bandage Contact Lenses Versus Eye Patching in Early Postoperative Period of Müller's Muscle-conjunctival Resection |
| Actual Study Start Date : | January 30, 2017 |
| Actual Primary Completion Date : | July 30, 2019 |
| Actual Study Completion Date : | August 30, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: bandage contact lens
A bandage contact lens was applied on the eye at the end of the surgery, and the eye was not covered with a patch.
|
Procedure: bandage contact lens
bandage contact lens |
|
Active Comparator: eye patching
Antibiotic eye ointment was applied on the eye, and the eye was covered with a patch at the end of the surgery.
|
Procedure: bandage contact lens
bandage contact lens |
- patient comfort [ Time Frame: 1 week ]VAS scores, (0: lowest; 10: highest)
- patient comfort [ Time Frame: 1 week ]TBUT score, (the minimum score was 0, and the maximum score was 15)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients who had unilateral ptosis and underwent unilateral MMCR
Exclusion Criteria:
- Patients were excluded if they had previous eyelid surgery or had another known eye disease, such as ocular surface disorders, dry eye syndrome.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04554329
| Turkey | |
| Haydarpasa Numune Education and Research Hospital | |
| Istanbul, Marmara, Turkey, 34668 | |
| Responsible Party: | Mehmet Serhat Mangan, Medical Doctor, Haydarpasa Numune Training and Research Hospital |
| ClinicalTrials.gov Identifier: | NCT04554329 |
| Other Study ID Numbers: |
HNEAH-KAEK 2019/116 |
| First Posted: | September 18, 2020 Key Record Dates |
| Last Update Posted: | September 18, 2020 |
| Last Verified: | September 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
patient comfort |
|
Eyelid Diseases Eye Diseases |

